Silver Oak Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304K Hold
1,200
0.12% 62
2026
Q1
$293K Sell
1,200
-4
-0.3% -$932 0.13% 59
2025
Q4
$249K Hold
1,204
0.11% 64
2025
Q3
$223K Buy
+1,204
New +$206K 0.1% 73
2023
Q4
Sell
-1,769
Closed -$275K 63
2023
Q3
$275K Buy
1,769
+377
+27% +$62.2K 0.18% 51
2023
Q2
$230K Hold
1,392
0.15% 52
2023
Q1
$215K Hold
1,392
0.14% 54
2022
Q4
$245K Buy
1,392
+7
+0.5% +$1.21K 0.17% 45
2022
Q3
$226K Hold
1,385
0.17% 46
2022
Q2
$246K Sell
1,385
-48
-3% -$8.55K 0.17% 46
2022
Q1
$254K Buy
1,433
+43
+3% +$7.32K 0.17% 50
2021
Q4
$238K Buy
+1,390
New +$228K 0.15% 55

Other funds holding JNJ

Silver Oak Advisory Group's JNJ Position: Q2 2026 in Review

Silver Oak Advisory Group held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,200 shares worth $304K. The position accounts for 0.12% of the portfolio, ranked #62.

Silver Oak Advisory Group first reported a position in JNJ in Q4 2021 and has held it in 12 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Silver Oak Advisory Group held 1,200 shares of Johnson & Johnson worth $304K as of Q2 2026.
  • Silver Oak Advisory Group left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.12% of Silver Oak Advisory Group's portfolio in Q2 2026, its #62 holding.
  • Silver Oak Advisory Group first reported a position in Johnson & Johnson in Q4 2021 and has held it in 12 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Silver Oak Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.